Advanced Integrative Oncology for Advanced Cancer
AIMS Cancer Outcomes Study
- Sex
- Any
- Study type
- Observational
- Participants needed
- 500 (estimated)
- Sponsor
- Advanced Integrative Medical Science Institute · Other
This trial is looking for patients with advanced cancer who are receiving treatments at the AIMS Institute. Participants will help researchers understand outcomes of a specific cancer treatment.
You may be able to join if
- I am a new patient with a diagnosis of cancer.
- I am an established patient with a diagnosis of cancer receiving treatment at AIMS Institute.
- I am over 18 years old and can provide informed consent.
- I am younger than 18 years old and have parental or guardian consent.
- I have a confirmed diagnosis of cancer based on medical records.
You may not be able to join if
- I am not diagnosed with cancer.
- I am a telehealth patient.
- I cannot read or understand English well enough.
- I am unwilling to participate in the study.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your EligibilityThe overall aim is to describe disease-free survival (DFS) in early stage cancer patients and three-year overall survival (OS) outcomes in advanced stage cancer patients receiving Advanced Integrative Oncology (AIO) treatment in a prospective consecutive case series outcomes study. We will collect data and study outcomes for patients with cancer who receive care at AIMS Institute.
Loading trial locations…
No contact information available.